Drugs / Zabofloxacin
Zabofloxacin
also known as
zabofloxacin aspartate · zabofloxacin HCl · zabofloxacin hydrochloride · Zabofloxacine · Zabofloxacino
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials · 1 met primary | ||||||
| Phase 1 | NCT02212795 | May → Aug 2014 | — | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01341249 | Apr → May 2011 | — | Seoul National University Hospital | Completed | Met primary |
| Phase 21 trial | ||||||
| Phase 2 | NCT01081964 | Mar 2010 → Apr 2012 | — | IASO Pharma Inc. | Terminated | No outcome recorded Stop: Business |
| Phase 31 trial | ||||||
| Phase 3 | NCT01658020 | Aug 2012 → Jan 2014 | chronic obstructive pulmonary disease | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zabofloxacin | “pharmacokinetics of zabofloxacin, the main component of DW224aa(Test drug) and DW224a(Reference drug).” NCT01341249 ↗ |
| Known as | zabofloxacin aspartate | “the zabofloxacin aspartate 488 mg tablet (DW224aa, 366.5 mg as zabofloxacin)” PMID 23865727 ↗ Aug 2013 |
| Known as | zabofloxacin HCl | “The study is a Phase 2, global, prospective, multi-dose, double-blind, double-dummy, active-control, randomized, parallel-group, multicenter study of oral zabofloxacin HCl...” NCT01081964 ↗ |
| Known as | zabofloxacin hydrochloride | “the zabofloxacin hydrochloride 400 mg capsule (DW224a, 366.7 mg as zabofloxacin)” PMID 23865727 ↗ Aug 2013 |
| Known as | Zabofloxacine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107811 ↗ |
| Known as | Zabofloxacino | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107811 ↗ |
| Action | Inhibit | “potent and selective inhibitor of the essential bacterial type II topoisomerases and topoisomerase IV” PMID 23865727 ↗ Aug 2013 |
| Modality | Small molecule | “zabofloxacin (a fluoroquinolone antibiotic)” NCT01081964 ↗ |
| Route | Oral | “oral zabofloxacin HCl (400mg)” NCT01081964 ↗ |